GWAS have identified common germline DNA variants that are associated with various common human diseases. GWAS focussed so far on SNPs that have a frequency of >5% in the population ("common disease, common variant"). GWAS only explain only a small fraction of the heritability of many traits. For instance, the HapMap project provides catalogs of common SNPs in several human populations.
Cancer Genome sequencing studies have cataloged numerous somatic mutations. The somatic mutations are rarely shared between many cancer cohorts (even patients of same cancer subtype). This makes it difficult to distinguish driver mutations from pass-by mutations.
SVs are an important contributor to genome variation that are not uncommon. SVs include both
It has become clear that germline SVs encompass more bases than SNVs. The Database of Genomic Variants lists 66K CNVs and 1000 inversion variants in the human genome. CNVs are believed to account for ~20% of genetic variation in gene expression, having little overlap with SNP-related variation and can affect the expression of genes up to 300kb away from the variant (Lower et al, 2009).
Cancer can be seen as a micro-evolutionary process within a population of cells. SVs are important somatic changes for cancer, for instance BCR/ABL fusion gene through a translocation in CML or a translocation activates the MYC oncogene by fusing it with a stronger promoter in Burkitt's lymphoma. Solid tumors often have a complex karyotype and show extensive re-arrangements. This might result of a breakdown of DNA repair machinery.
A distinguishing feature of the different mechanisms is the amount of sequence similarity (homology) at the breakpoints of the SV.
It is unclear what are the contributions of these different SV-mechanisms.
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.